Back to search

United Kingdom· GB-APID-43019311000001102

Eladynos 80micrograms/40microlitres solution for injection 1.5ml pre-filled pens

A abaloparatide product containing abaloparatide, registered in United Kingdom by Theramex HQ UK Ltd. The same ATC class is registered in 12 of our 19 countries.

ATC H05AA04

Checked against NHS dm+d (United Kingdom) on

Informational only — not a medical device.

SOURCE REGISTER · GBNHS dm+d (United Kingdom)normalisedEladynos 80micrograms/40microlitres s…ATCH05AA04REGISTER NO.GB-APID-4301931100000…PACKS LISTED1CHECKEDSeptember 13, 2026

Where it is registered

Abaloparatide is registered in 12 of 19 countries.

Countries holding a registration under ATC H05AA04 (abaloparatide), each read from that country’s own register.

  • This record: United Kingdom, from NHS dm+d (United Kingdom)
  • 8 of them publish a price we can compare per daily dose

Abaloparatide · ATC H05AA04

12 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

NHS dm+d (United Kingdom)
Active substance
Abaloparatide
Manufacturer
Theramex HQ UK Ltd
Country
United Kingdom (GB)
ATC code
H05AA04
ATC class
Abaloparatide
Defined daily dose
80 mcg, P
Reimbursed
Not published by this register
Source register
NHS dm+d (United Kingdom)
Last checked
September 13, 2026

Packs & prices · 1

  • gtin
    05060632509864

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

2 interactions on record for abaloparatide.

Graded by severity as the source publishes them — 2 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Abaloparatide · interactions on record

2 records

  • 2 moderate

Most severe, free to view

  • CalcipotriolD05AX02moderate
  • CalcitriolD05AX03moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/4b68c027-630c-4069-8a37-a7744f0c4090
GET /v1/drugs/4b68c027-630c-4069-8a37-a7744f0c4090?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "apid": "43019311000001102",
  "desc": "Eladynos 80micrograms/40microlitres solution for injection 1.5ml pre-filled pens (Theramex HQ UK Ltd)",
  "form": "Solution for injection",
  "vpid": "43170311000001109",
  "source": "dmd",
  "vtm_id": "774395000",
  "strength": "2 mg",
  "substance": "Abaloparatide",
  "ingredient": "Abaloparatide",
  "supplier_code": "36444411000001103"
}

See everything about abaloparatide.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.